Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
MedImmune, LLC
Scientific Title
A Phase 1b/2, Open-label, Multicenter Study of Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First-line Therapy in Metastatic Microsatellite-stable Colorectal Cancer